Clinical trial
Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable…
NCT00183872 · University of Southern California, Other · Completed
Key facts
| NCT number | NCT00183872 |
|---|---|
| Title | Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma |
| Official title | Phase II Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma |
| Lead sponsor | University of Southern California, Other |
| Collaborators | Sanofi Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastric Cancer, Esophageal Neoplasms |
| Intervention type | Drug |
| Interventions | irinotecan, docetaxel |
| Enrollment | 40 |
| Start date | Apr 14, 2005 |
| Primary completion | Oct 20, 2014 |
| Completion | Oct 20, 2015 |
| First posted | Sep 16, 2005 |
| Last update posted | Feb 19, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: